Cargando…

Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials

BACKGROUND: This study aims to evaluate the clinical efficacy and safety of rimegepant for the treatment of migraine in adult patients using a meta-analysis. METHODS: The PubMed, EMBASE, and Cochrane Library were searched up to March 2022. Only randomized controlled trials (RCTs) that evaluated migr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qinghui, Wang, Shuangmei, Zhu, Yi, Lin, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318539/ https://www.ncbi.nlm.nih.gov/pubmed/37409024 http://dx.doi.org/10.3389/fneur.2023.1205778

Ejemplares similares

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials
por: Gao, Bixi, et al.
Publicado: (2020)

Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials
por: Gao, Bixi, et al.
Publicado: (2020)

ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
por: Franklin, Meg, et al.
Publicado: (2020)

Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings
por: Polavieja, Pepa, et al.
Publicado: (2022)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
por: Blair, Hannah A.
Publicado: (2023)

The Efficacy and Safety of Acupuncture for Prophylaxis of Vestibular Migraine: A Study Protocol for a Randomized Controlled Trial
por: Hu, Tianye, et al.
Publicado: (2021)

Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
por: Blair, Hannah A.
Publicado: (2023)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
por: Johnston, Karissa M., et al.
Publicado: (2021)

Noninvasive vagus nerve stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials
por: Song, Dong, et al.
Publicado: (2023)

Galcanezumab for the Management of Migraine: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
por: Abu-Zaid, Ahmed, et al.
Publicado: (2020)

Efficacy of Cognitive-Behavioral Therapy for the Prophylaxis of Migraine in Adults: A Three-Armed Randomized Controlled Trial
por: Klan, Timo, et al.
Publicado: (2022)

Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials
por: Ren, Junwei, et al.
Publicado: (2022)

Efficacy of Acupuncture Treatment of Migraine Delivered by Senior or Junior Acupuncturists: Study Protocol for a Randomized Controlled Trial
por: Zhou, Jun, et al.
Publicado: (2022)

Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)
por: Oliveira Gonçalves, Ana Sofia, et al.
Publicado: (2022)

The efficacy and safety of antiepileptics in the prophylaxis of pediatric migraine: the meta-analysis of randomized controlled trials
por: Jia, Guoyong, et al.
Publicado: (2021)

Safety and Efficacy of Zavegepant in Treating Migraine: A Systematic Review
por: Khan, Zainab Z, et al.
Publicado: (2023)

Sudden Caffeine Withdrawal Triggers Migraine—A Randomized Controlled Trial
por: Alstadhaug, Karl B., et al.
Publicado: (2020)

Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials
por: Yan, Zeya, et al.
Publicado: (2022)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors
por: Pan, Kylie S., et al.
Publicado: (2020)

Is the right way to go in between?: Rimegepant as needed provides preventive benefit. A comment on: monthly migraine days, tablet utilization, and quality of life associated with rimegepant—post hoc results from an open label safety study (BHV3000–201)
por: Gantenbein, Andreas R., et al.
Publicado: (2023)

Efficacy and Safety of Oral Chinese Herbal Medicine for Migraine: A Systematic Review and Meta-Analyses Using Robust Variance Estimation Model
por: Lyu, Shaohua, et al.
Publicado: (2022)

Safety and Efficacy of Early Rehabilitation After Stroke Using Mechanical Thrombectomy: A Pilot Randomized Controlled Trial
por: Wang, Wei, et al.
Publicado: (2022)

Neurological mechanism and treatment effects prediction of acupuncture on migraine without aura: Study protocol for a randomized controlled trial
por: Hong, Jiahui, et al.
Publicado: (2022)

Auriculotherapy in prevention of migraine attacks: an open randomized trial
por: Michel-Cherqui, Mireille, et al.
Publicado: (2023)

Efficacy and Safety of Deep Brain Stimulation in the Treatment of Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Bratsos, Sosipatros, et al.
Publicado: (2018)

Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials
por: Giovanardi, Carlo Maria, et al.
Publicado: (2020)

Efficacy and Safety of a Novel Thrombectomy Device in Patients With Acute Ischemic Stroke: A Randomized Controlled Trial
por: Zhang, Yongxin, et al.
Publicado: (2021)

Comparative efficacy and safety of multiple acupuncture therapies for post stroke cognitive impairment: a network meta-analysis of randomized controlled trials
por: Liu, Yang, et al.
Publicado: (2023)

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
por: Johnston, Karissa M, et al.
Publicado: (2022)

Comparative efficacy of acupuncture-related therapy for migraine: A systematic review and network meta-analysis
por: Song, Yanjuan, et al.
Publicado: (2022)

Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis
por: Zhong, Jiugen, et al.
Publicado: (2022)

Efficacy and safety of Buyang Huanwu Decoction in the treatment of post-stroke depression: A systematic review and meta-analysis of 15 randomized controlled trials
por: Zhen, Kun, et al.
Publicado: (2022)

The efficacy and safety of Chinese herbal medicine as an add-on therapy for amyotrophic lateral sclerosis: An updated systematic review and meta-analysis of randomized controlled trials
por: Liao, Yingdi, et al.
Publicado: (2022)

Efficacy and safety of acupuncture combined with auricular acupressure for smoking cessation: A study protocol of a multicentre, randomized, controlled clinical trial
por: Zeng, Jinchun, et al.
Publicado: (2022)

Erenumab safety and efficacy in migraine: A systematic review and meta-analysis of randomized clinical trials
por: Zhu, Changyu, et al.
Publicado: (2019)

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
por: Johnston, Karissa, et al.
Publicado: (2022)

Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
por: Mechtler, Laszlo, et al.
Publicado: (2022)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Efficacy of Scalp Acupuncture in Patients With Post-stroke Hemiparesis: Meta-Analysis of Randomized Controlled Trials
por: Huang, Yuan-Ju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r0crse4a4q6h4hf9h6umr0ihe6